Aeterna Zentaris
AEZS
#10801
Rank
NZ$31.09 M
Marketcap
NZ$10.16
Share price
2.14%
Change (1 day)
N/A
Change (1 year)

EPS for Aeterna Zentaris (AEZS)

EPS in 2023 (TTM): NZ-$7.53

According to Aeterna Zentaris's latest financial reports the company's current EPS (TTM) is NZ-$3.64. In 2022 the company made an earnings per share (EPS) of NZ-$8.29 a decrease over its 2021 EPS that were of NZ-$3.48.

EPS history for Aeterna Zentaris from 1999 to 2023

Annual EPS

Year EPS Change
2023 (TTM)NZ-$7.53-9.23%
2022NZ-$8.29138.27%
2021NZ-$3.48-48.05%
2020NZ-$6.70-56.88%
2019NZ-$15.54-240%
2018NZ$11.10-122.94%
2017NZ-$48.39-54.96%
2016NZ-$107.43-93.07%
2015NZ-$1,55020.13%
2014NZ-$1,290-225.69%
2013NZ$1,026-122.24%
2012NZ-$4,616-42.55%
2011NZ-$8,035-12.98%
2010NZ-$9,234-17.46%
2009NZ-$11,187-62.5%
2008NZ-$29,83283.66%
2007NZ-$16,243-227.16%
2006NZ$12,774105.81%
2005NZ$6,207-334.56%
2004NZ-$2,646-79.94%
2003NZ-$13,19313.5%
2002NZ-$11,624604.55%
2001NZ-$1,650-84.33%
2000NZ-$10,531275.3%
1999NZ-$2,806

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Novartis
NVS
NZ$9.32-356.23%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Sanofi
SNY
NZ$3.38-192.88%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
NZ$8.03-320.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
NZ-$0.64-82.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Halozyme Therapeutics
HALO
NZ$6.25-271.80%๐Ÿ‡บ๐Ÿ‡ธ USA